ZMIZ1 and myeloid sarcoma: ZMIZ1 expression levels are threefold lower in EBVEBNA2+ Ramos cells compared to uninfected Ramos cells, consistent with a previous report by Fewings et al. (2017) describing decreased ZMIZ1 protein expression in MS patient blood samples.